Cost Effective Scale-Up of the Flow Synthesis

This invention is continuous flow reactor technology used to manufacture active pharmaceutical ingredients (APIs) for various drugs. 

These include AIDS (Emtricitabine, Lamivudine and Efavirenz), TB (Isoniazid), influenza (Tamiflu) and diabetes (Gliclazide, chlorpropamide, glipizide, glibenclamide and tolbutamide) drugs.

The project outcomes demonstrated that these can be manufactured cost effectively using continuous flow method compared to when they are produced using the conventional batch manufacturing process.